[Federal Register Volume 60, Number 35 (Wednesday, February 22, 1995)]
[Notices]
[Pages 9852-9853]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-4242]



-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institute of Health


National Cancer Institute; Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the National 
Cancer Institute (NCI) advisory committee meetings.
    These meetings will be open to the public as indicated below with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the contact person in 
advance of the meeting.
    Ms. Carole Frank, NCI Committee Management Officer, National 
Institutes of Health, Executive Plaza North, Room 630E, 6130 Executive 
Boulevard MSC 7405, Bethesda, Maryland 20892-7405, (301) 496-5708, will 
provide summaries of the meetings and rosters of committee members upon 
request. Substantive program information may be obtained from the 
contacts listed below.

Committee Name: Developmental Therapeutics Contracts Review Committee.
Contact Person: Dr. C. Michael Kerwin, Scientific Review Administrator, 
DEA, NCI, NIH, Executive Plaza North, Room 601A, 6130 Executive 
Boulevard, Rockville, MD 20852-7405, Telephone: (301) 496-7421
Date of Meeting: March 3, 1995
Place of Meeting: Executive Plaza North, Conference Room J, 6130 
Executive Boulevard, Rockville, MD 20852
Closed: 9 am to adjournment
Agenda: Review, discussion and evaluation of individual contract 
proposals.

Committee Name: Board of Scientific Counselors, Division of Cancer 
Biology, Diagnosis, and Centers
Contact person: Dr. Ihor J. Masnyk, Executive Secretary, NCI, NIH, 
Building 31A, Room 3A11, 9000 Rockville Pike, Bethesda, MD 20892-2440, 
Telephone: (301) 496-3251
Date of Meeting: March 6, 1995
Place of Meeting: Building 31C--Conference Room 10, National Institutes 
of Health, 9000 Rockville Pike, Rockville, MD 20892
Open: 8:30 am to adjournment
Agenda: Discussion and review of the division budget and review of 
concepts for grants and contracts.

    These meetings will be closed, as indicated, in accordance with 
provisions set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, 
U.S.C. Proposals and the discussions could reveal confidential trade 
secrets or commercial property such as patentable material and personal 
information concerning individuals associated with the proposals, 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.
    This notice is being published less than fifteen days prior to the 
meeting due to the urgent need to meet timing limitations imposed by 
the review cycle.

(Catalog of Federal Domestic Assistance Program Numbers: 93.393, 
Cancer Cause and Prevention Research; 93.394, Cancer Detection and 
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, 
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
Cancer Research Manpower; 93.399, Cancer Control)

    [[Page 9853]] Dated: February 15, 1995.
Susan K. Feldman,
Committee Management Officer, National Institutes of Health.
[FR Doc. 95-4242 Filed 2-21-95; 8:45 am]
BILLING CODE 4140-01-M